Related Experiment Video
Updated: Apr 27, 2026

09:48
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
866
MicroRNAs and bone metastasis: a new challenge.
Martine Croset1, Daniele Santini2, Michele Iuliani3
1Institut national de la santé et de la recherche médicale (INSERM), UMR 1033, Lyon F-69008, France. martine.croset@inserm.fr.
Molecules (Basel, Switzerland)
|July 15, 2014
Summary
MicroRNAs (miRNAs) regulate gene expression and are crucial in the development of bone metastases. Understanding miRNA functions offers insights into cancer cell behavior and bone colonization.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Bone metastasis development involves complex, multi-step processes.
- MicroRNAs (miRNAs) are small RNA molecules that regulate gene expression by targeting mRNAs.
- Deregulation of miRNAs impacts cancer cell invasion, survival, and bone microenvironment interactions.
Purpose of the Study:
- To review the functions and molecular mechanisms of miRNAs in bone metastasis.
- To highlight the role of miRNAs in cancer cell intravasation and bone colonization.
- To explore miRNA signatures as potential determinants of clinical aggressiveness.
Main Methods:
- Literature review of current advances on miRNA functions in bone metastasis.
- Analysis of molecular mechanisms underlying miRNA-mediated gene regulation.
- Examination of tissue-specific miRNA expression patterns in bone metastasis.
Main Results:
- miRNAs regulate key steps in metastasis, including epithelial-mesenchymal transition, motility, and survival.
- miRNA networks influence cancer cell intravasation and extravasation.
- Tissue-specific miRNAs are critical for bone tropism, homing, and colonization.
- miRNA expression signatures may predict clinical aggressiveness of bone metastases.
Conclusions:
- miRNAs play a significant role in the development of bone metastases.
- Targeting miRNA pathways presents potential therapeutic strategies for bone metastasis.
- miRNA profiling could aid in predicting patient outcomes and guiding treatment decisions.
Related Concept Videos
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs
20.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.9K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K

